Howard Higley (contractor to CIP to follow these projects) and Carolyn Sigworth (SSA) and Gary Kelloff

endorsed by FDA as biomarker qualification processes.


2 trials:
<ul>
  <li>
    Lymphoma collected by OSU Jacko (therapy)  under 25 cases thus far.
  </li>
  <li>
    ACRIN 6678 Lung, run by Weber, PET CT of the Lung (monitoriing rather than therapy) (maybe some IP issues on data)
  </li>
</ul>
Accrual is not close


Three-way FNIH project.  Us, FDA, Companies.

These are open trials, need to satisify FNIH &#34;incubation period&#34; security.


Carl will call Higley today.